Biology subjects

Tran, Q. T.

Publications and source records attributed to Tran, Q. T..

4 recordsLinked to original sources

bioRxiv2024

Endoplasmic Reticulum Alterations in Living Cells Expressing INF2 Variants Causing Glomerulosclerosis and Peripheral Neuropathy

The endoplasmic reticulum (ER) is a single dynamic, and continuous network, which mediates a variety of biological processes. The ER spreads throughout the cytoplasm as an interconnected network mainly consisting of flat (sheets) or reticular (tubules) networks. Such ER integrity is regulated by actin-microtubule interaction. INF2 is an actin assembly factor that exclusively located in ER and is mutated in hereditary form of glomerulopathy (focal segmental glomerulosclerosis, FSGS) and peripheral neuropathy (Charcot-Marie Tooth, CMT-DIE, MIM 614455). It remains unclear how INF2 variants could affect ER morphology. High-resolution, live-imaging of HeLa cells revealed that pathogenic INF2-CAAX variants disrupt peripheral ER complexity, generating focal clustering of polygonal tubules and preferential sheet-like appearance. G73D (causing CMT+FSGS) induced more remarkable alterations than T161N, N202S and R218W (leading to FSGS). Both actin and microtubule inhibitors shifted the ER balance towards sheet predominance and focal compaction of ER tubules, suggesting the role of cytoskeleton in shaping tubular ER networks. INF2 variants induced mitochondria fragmentation with peripheral mis-distribution. The mitochondrial alterations correlated with the degree of cytoskeletal disorganization, leading to defective respiratory function. Moreover, lysosomal trafficking was restricted by INF2 variants in the cell cortex. These organelle-cytoskeletal interactions were more remarkably impaired by CMT+FSGS variant than in FSGS variants. Our observations underscore that INF2 variants disrupt ER integrity by disorganizing cytoskeletons, which leads to defective mitochondria function and vesicle trafficking in INF2 disorders. INF2 CMT+FSGS variants impair ER-organelles interaction more prominent than FSGS variants, suggesting the existence of specific mediators for CMT+FSGS variants.

cell biology↗

bioRxiv2019

Comprehensive molecular characterization of pediatric treatment-induced high-grade glioma: A distinct entity despite disparate etiologies with defining molecular characteristics and potential therapeutic targets

Treatment-induced high-grade gliomas (TIHGGs) are an incurable late complication of cranial radiation therapy or combined radiation/chemotherapy used to treat pediatric cancer. We assembled a cohort of 33 TIHGGs from multiple institutions. The primary antecedent malignancies were medulloblastoma, acute lymphoblastic leukemia, astrocytoma, and ependymoma. We performed methylation profiling, RNA-seq, and genomic sequencing (whole-genome or whole-exome) on TIHGG samples. Methylation profiling revealed that TIHGGs cluster primarily with the pediatric receptor tyrosine kinase I subtype (26/31 samples). Common TIHGG copy-number alterations include Chromosome (Ch.) 1p loss/1q gain, Ch. 4 loss, Ch. 6q loss, and Ch. 13 and Ch. 14 loss; focal alterations include PDGFRA and CDK4 gain and loss of CDKN2A and BCOR. Relative to de novo pediatric high-grade glioma (pHGG), BCOR loss (p=0.004) and CDKN2A loss (p=0.005) were significantly increased. Transcriptomic analysis identified two distinct TIHGG subgroups, one with a lesser mutation burden (0.12 mut/Mb), Ch. 1p loss/1q gain (5/6 samples), and stem cell characteristics, and one with a greater mutation burden (1.08 mut/Mb, p<0.0002), depletion of DNA repair pathways, and inflammatory characteristics. We observed increased chromothripsis in TIHGG versus pHGG (67% vs. 31%, p=0.036), which was associated with extrachromosomal circular DNA-mediated amplification of PDGFRA and CDK4. In vitro drug screening in one primary, patient-derived TIHGG cell line from each expression subgroup identified microtubule inhibitors/stabilizers, DNA-damaging agents, MEK inhibition, and, in the inflammatory subgroup, proteasome inhibitors as potentially effective therapies. This study provides a comprehensive molecular profile of TIHGG, including mechanistic insights to TIHGG oncogenesis, and identifies potentially effective therapeutic modalities for further investigation.

cancer biology↗

bioRxiv2019

Skeletal Muscle mTORC1 Activation Increases Energy Expenditure and Reduces Longevity in Mice

The mechanistic target of rapamycin (mTORC1) is a nutrient responsive protein kinase complex that helps co-ordinate anabolic processes across all tissues. There is evidence that signaling through mTORC1 in skeletal muscle may be a determinant of energy expenditure and aging and therefore components downstream of mTORC1 signaling may be potential targets for treating obesity and age-associated metabolic disease. Here, we generated mice with Ckmm-Cre driven ablation of Tsc1, which confers constitutive activation of mTORC1 in skeletal muscle and performed unbiased transcriptional analyses to identify pathways and candidate genes that may explain how skeletal muscle mTORC1 activity regulates energy balance and aging. Activation of skeletal muscle mTORC1 produced a striking resistance to diet-and age-induced obesity without inducing systemic insulin resistance. We found that increases in energy expenditure following a high fat diet were mTORC1-dependent and that elevated energy expenditure caused by ablation of Tsc1 coincided with the upregulation of skeletal muscle-specific thermogenic mechanisms that involve sarcolipin-driven futile cycling of Ca2+ through SERCA2. Additionally, we report that constitutive activation of mTORC1 in skeletal muscle reduces lifespan. These findings support the hypothesis that activation of mTORC1 and its downstream targets, specifically in skeletal muscle, may play a role in nutrient-dependent thermogenesis and aging.

physiology↗

bioRxiv2017

Glucocorticoid-Induced Metabolic Disturbances are Exacerbated in Obesity

Obesity and chronically elevated glucocorticoids result in similar co-morbidities, but the effect of a combination of these ailments on metabolic outcomes is unclear. Measures of glucose homeostasis and markers of hepatic lipid accumulation were assessed to determine whether obesity exaggerated the effects of dexamethasone-induced metabolic disturbances. The combination of obesity and glucocorticoids resulted in hepatic steatosis and synergistic impairments in insulin sensitivity and this was matched with synergistic elevations in markers of lipolysis. These findings suggest lipolysis may be a key player in glucocorticoid-induced insulin resistance and fatty liver in people with obesity.

physiology↗